Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1

Pharmacology, Toxicology and Pharmaceutical Science

• Stavudine 100%
• Nevirapine 80%
• Nelfinavir 80%
• Lamivudine 50%
• Ritonavir 30%
• Human Immunodeficiency Virus 1 30%
• RNA Directed DNA Polymerase Inhibitor 20%
• Drug 20%
• RNA 10%
• Tolerability 10%
• Viremia 10%
• Proteinase Inhibitor 10%
• Nonnucleoside Reverse Transcriptase Inhibitor 10%
• Nucleoside Analog 10%
• Clinical Trial 10%

INIS

• children 40%
• humans 30%
• therapy 30%
• viruses 30%
• drugs 20%
• suppression 20%
• infants 20%
• clinical trials 10%
• pediatrics 10%
• rna 10%
• AIDS 10%
• nucleosides 10%